Professional Documents
Culture Documents
23.1 Introduction
Pteridophytes (Fern and fern allies) have a long geological history on earth as pioneer
plants which colonized our planet for millions of years. They form one of the oldest
land plant groups on earth constituted by a vast group of vascular cryptograms including
more than 10,000 species grown in varied climatic regions and geographically distrib-
uted. The medicinal use of ferns as a source of relief and treatment of various ailments
is as old as humankind itself. Some of these uses of ferns have been transmitted through
centuries. Later on, pharmacological and phytochemical investigations have tended to
demystify and bring better knowledge about the contained plant metabolites and their
biological properties.
Folk medicinal uses of ferns have been transmitted through centuries orally from gen-
eration to generation or recorded in ancient literature of traditional pharmacopoeia.
Collected data from different countries report ethnopharmacological investigations on
medicinal plant uses including ferns and allies, which have been used since ancient
times. Different fern species throughout the world are presently utilized to treat various
ailments, mostly in developing countries, where herbal products still occupy a signifi-
cant place in primary healthcare for cultural and economic reasons. The non exhaus-
tive list given in Table 23.1 shows that most of the plants are used to cure common
diseases because of their purgative and antibacterial properties or to treat gastric and
renal infections; they were also used as diuretics, pain killers (to treat headache, stom-
achaches, gastrointestinal aches) and anti-inflammatory agents. Related literature
R. Ho (*)
Laboratoire de Pharmacognosie et Phytochimie, Ecole de Pharmacie Genève
Lausanne – Université de Genève, 30, Quai Ernest-Ansermet – CH-1211, Genève 4, Switzerland
e-mail: raimana.ho@unige.ch
H. Fernández et al. (eds.), Working with Ferns: Issues and Applications, 321
DOI 10.1007/978-1-4419-7162-3_23, © Springer Science+Business Media, LLC 2011
Table 23.1 Ferns used in traditional medicine
322
amenorrhea
Kumaun Himalaya Laxative, expectorant, in Upreti et al. (2009)
the treatment of cold
Neottopteris nidus Hainan island (China) In the treatment of rheumatoid Zheng and Xing (2009)
arthritis
Blechnaceae Blechnum occidentale Brazil Anti-inflammatory, in urinary Nonato et al. (2009)
infections, in pulmonary and
liver disease treatments
orientale India Impotence Dhiman (1998)
323
(continued)
Table 23.1 (continued)
324
(continued)
Table 23.1 (continued)
326
(continued)
Table 23.1 (continued)
328
described that different parts of the plants (rhizomes, stems, fronds, pinnae, and
spores) were utilized in various ways using recipes specific to each region. Plant-based
remedies are delivered either by external application (topical applications such as
lotions, frictions, poultices, eye drops, fumigations, baths, and gargles) or by internal
intake formulated in different ways (potions) (Grepin and Grepin 1984; Pétard 1986;
Whistler 1992a, b; Cambie and Ash 1994; Whistler 1996; Bloomfield 2002; Lee et al.
2008; Upreti et al. 2009; Zheng and Xing 2009).
Poor specificity of the remedy is also noticed, as the same plant may be used to treat
different ailments, for example, the uses of Microsorum scolopendria in Polynesia
(cleansing baths for newborns, dysmenorrheas, gonorrheas, leukorrheas, sore throats,
asthma, purges, wound healing, antiemetic, sprain and bone injury treatments) or the
uses of Adiantum capillus-veneris in Kumaun Himalaya (febrifuges, diuretics, expec-
torant, emmenagogue, bronchitis, general tonic, and cold and cough treatments)
(Upreti et al. 2009). On the other hand, it is often reported that one specific remedy
may include the use of different plants as ingredients for the same medicinal prepara-
tion, which is the case of the traditional Chinese remedy called “Gusuibu” containing
six different ferns (Drynaria fortunei, Pseudodrynaria coronans, Davallia divaricata,
Davallia mariesii, Davallia solida, and Humata griffithiana) (Chang et al. 2007).
Geographical variations on medicinal plant uses are also evident in Table 23.1,
for example, the use of Lygodium flexuosum in the Kumaun Himalaya region
(expectorant, rheumatism, sprains, scabies…) differs from its use in Yunnan China
region (rheumatoid lumbago, gallstone) (Lee et al. 2008; Upreti et al. 2009). Some
specific regional medicinal uses reflect cultural roots such as plants particularly
used for the umbilical cicatrisation of newborn children (Grepin and Grepin 1984;
Pétard 1986; Bloomfield 2002).
For centuries, because of botanical and taxonomic confusion of closely related taxa,
groups of plants that were known with the same vernacular name were used for the
same medicinal indications. So, for example, “Calaguala” was the vernacular name
attributed to different Polypodium species grown in the South American region, which
are traditionally used for the same therapeutic indications (Pareja 1988). In the same
way, “Metuapua’a” is the common vernacular name of the widely used Polynesian
medicinal fern corresponding to, at least, two different species of Microsorum
(M. scolopendria and M. membranifolium), which are also used for the same treat-
ments (Ho et al. 2007, 2008). Such botanical confusion may cause safety warnings
when toxic fern species are involved in these closely related species or when the presence
or absence of the active principle may have healthy or harmful consequences. This
question is closely related to the chemical composition of these medicinal ferns.
Biological activity and phytochemical assessments of fern extracts have been carried
out for some medicinal fern species over the world. For that purpose, different
in vitro and in vivo bioassays were performed to evaluate the biological potency of
whole extracts, fractions, or isolated compounds. The chemical constituent
23 Ferns: From Traditional Uses to Pharmaceutical Development 331
23.3.1 Terpenoids
Terpenoids constitute the largest chemical group found in ferns including mainly
triterpenoids, diterpenoids, and sesquiterpenoids having various biological interests.
23.3.2 Triterpenoids
23.3.3 Diterpenoids
Phenolic compounds Isovanillic acid; ferulic acid; Cytotoxic, antitumor Hu and Zheng (2004),
licoagrochalcone D; vanillin; Hu and Zheng
5-(3″-methylbutyl)-8- (2005), Ouyang,
methoxyfurocoumarin; Yang and Kong
2-(3¢-hydroxy-3¢-methylbutyl)- (2008), Zheng, Hu
4-hydroxy-5-methoxyphenol-1- and Hu (2008b)
O-b-d-glucopyranoside
a
Phymatodes scolopendria is a synonym of Microsorum scolopendria (Nooteboom 1997)
335
336 R. Ho et al.
a
R1 OH R2
CH3 CH3 CH3
R2 R1
R2 CH3 CH3
CH3
HO CH3 CH3
OH CH3
OH
CH3
HO CH3 CH3
R1
H
O R1=CH3 R2=CH3 Filicene R1=isopropyl R2=H Fern-7-ene
R1=R2=H Ecdysone R1=CHO R2=CH3 Filicenal
R1=H R2=Me 20-deoxymakisterone R1=CH3 R2=CH2-OH Filicinol B R2
R1=OH R2=H 20-hydroxyecdysone CH3 R3
R1
R1=OH R2=Me Makisterone A
R1=OH R2=Et Makisterone C R4 CH3
OH
OH
R
CH3
OH
HO CH3 CH
3
b c O
R3 R1=M R2=β-CH3 R3=OH Multifidoside A
HO
R2 R1=M R2=α-CH3 R3=OH Multifidoside B
R
H R1=H R2=α-CH3 R3=M Multifidoside C
OH
R1 O OH
H O
HO R=H Pterokaurane M1 M= O
O
R=OH Pterokaurane M2 HO OH
HO
OH
OH OH
HO OH
H OH
H
O
H Pterokaurane M3 H3C OH
OH
CH3 Ptaquiloside
H
H3C OH O
Fig. 23.1 (a) Examples of triterpenoid components present in ferns. (b) Examples of diterpenoid
components present in ferns. (c) Examples of sesquiterpenoid components present in ferns
23.3.4 Sesquiterpenoids
OH OCH3
O
O
H3C
OH OH OCH3
O O Arctigenin OH
O O
HO 4-vinylphenol
OH O
OCH3 OH
Davallialactone
OH
O O OCH3
H
H3CO CH3
O CH3
OH O
HO HO O CH3
H OH
Licoagrochalcone D
Vanillic acid
O
OCH3 HO CO2H
HO OH
OCH3
O
Phylligenin
HO O
OH HO OH
OH
O OH OH
OH Quinic acid
Chlorogenic acid OH
OH Cafffeic acid
HO OH
O O O OH
HO
HO O
HO OH
HO OH
O
HO OH
O
HO O
O O
OH O
OH
HO O
Rutin HO
HO
OR HO
R=CH3CO Kaempferol-3-O-α-arabino-(2‘’acetyl)-furanosyl-7-O-α-L-rhamnopyranoside OH
R=H Kaempferol-3-O-α-arabinofuranosyl-7-O-α-L-rhamnopyranoside
OH
HO O
OH
H
R2 OH
OH Kaempferol
O OH OH O
OH
HO O OH
OH
HO HO O
OH
O OH O
HO OH
R1=CH2-OH R2=CH3 Violanthin
OH
R1 Epicatechin
R1=CH3 R2=CH2-OH Isoviolanthin
Me
H
H
N O
Lycodine Huperzine B
N N
H HN
O R
H
N O R=H Cernuine
N N R=OH Lycocernuine
Huperzine A H H
H2N Me
H H
Me Me
H O R
R=H Lycopodine
H Huperzine E H R=OH Lycodoline
N OH N O
bracken species and polypodiaceous ferns, some of them being used in traditional
medicine. For example, Pteris multifida contains multifidosides (A and B)
(Figure 23.1c) having significant inhibitory effects against HepG2 cells and K562
cells with IC50 value at a micromolar level, which revealed that cytoxicity could be
related to the antitumor activity of this medicinal plant (Ge et al. 2008; Ouyang
et al. 2008). This latter case is a good example showing a coherence between the
revealed pharmaceutical properties of the molecules contained in the plant and its
traditional use.
Pteridium aquilinium, a bracken fern that was also used as a medicinal plant in
some regions, contains ptaquiloside (Fig. 23.1c), a pteroside compound well
known as a carcinogenic and toxic molecule causing severe health problems
(Yamada et al. 2007). The need for pharmacovigilance measures must be pointed
out to limit the medicinal use of such a hazardous plant (Alonso-Amelot 2002;
Yamada et al. 2007).
23.3.5 Phenolic Compounds
acidic functions, are frequently found in different species (Fig. 23.2). Various
biological activities are attributed to these compounds, mainly antioxidant and
photoprotectant activities reported for the medicinal fern Polypodium leucotomos
that was also used as the active principle of skin care formulas, especially for psoria-
sis treatment (Lucca 1992; House et al. 1994; Gonzalez, Gilaberte and Philips 2010).
Atherosclerosis prevention potential of Pteris ensiformis is supposedly attributed to
its glycosylated phenolic acid constituent (7-O-caffeoylhydroxymaltol-3-b-d-
glucopyranoside) (Wei et al. 2007).
Chalcone derivatives constitute a class of phenolic compounds found in medicinal
ferns. Pityrogramma calomelanos contain the dihydrochalcone component, the
cytotoxicity of which is supposed to be responsible of its anticancer potential
(Martin et al. 2006). Licoagrochalcone D is also another chalcone compound present
in Pteris multifida that may contribute to its overall biological activity (Hu and
Zheng 2005).
The traditional medicine uses of Asplenium trichomanes, including as an emme-
nagogue and abortifacient (Negri 1979; Moerman 1998; Pomini 1990), were
related to revealed in vitro estrogenic activity of the plant extracts and isolated
compounds. Some of these estrogenic active components are phenolic derivatives
such as 4-vinylphenol, phylligenin, and arctigenin shown in Fig. 23.2 (Dall’Acqua
et al. 2009).
23.3.6 Flavonoids
23.3.7 Alkaloids
Lycopodiaceae (fern in sensu latu) is a family that contains typical alkaloids, some of
them contained in medicinal ferns. Lycopodium alkaloids comprise diverse compounds
that often possess unusual skeletons but can be classified in four major structural
groups: lycopodine, lycodine, fawcettimine, and miscellaneous (Ma et al. 2007).
Huperzine A, a lycodine alkaloid having a quinolizidine skeleton, was isolated from the
Chinese folk medicine Huperzia serrata, belonging to the Huperziaceae family, used to
340 R. Ho et al.
cure schizophrenia (and other diseases such as contusions, strains, swellings, and
myasthenia gravis) and was found to be a strong inhibitor of acetylcholinesterase and
so having interesting neuroprotective effects as a potential treatment for Alzheimer
disease and vascular dementia (Liu et al. 1986a, b; Ma et al. 2007; Hostettmann et al.
2006; Zhang et al. 2008). Revealed biological activity of huperzine A can be related to
the traditional use of Huperzia serrata as a treatment against schizophrenia. Examples
of Lycopodium alkaloids found in medicinal ferns belonging to the Lycopodiaceae fam-
ily, are also shown in Fig. 23.4, some of them reported to possess acetylcholinesterase
inhibition activity (Ma et al. 2007).
23.4 Pharmaceutical Development
23.4.1 Huperzine A
with promising therapeutic applications, and still motivate further investigations for a
better understanding of its mode of action (Zhang et al. 2008).
References
Ajikumaran, S.N., Shylesh, B.S., Gopakumar, B., and Subramoniam, A. 2006. Anti-diabetes and
hypoglycaemic properties of Hemionitis arifolia (Burm.) Moore in rats. Journal of
Ethnopharmacology 106:192–197.
Alonso-Amelot, M.E. 2002. The chemistry and toxicology of bioactive compounds in bracken
fern (Pteridium sp.), with special reference to chemical ecology and carcinogenesis. Studies in
Natural Products Chemistry 26:685–740.
342 R. Ho et al.
Anderson, C., Fuller, F., and Epstein, W.W. 1979. Nonpolar pentacyclic triterpenes of the medicinal
fern Polypodium subpetiolatum. Journal of Natural Products 42:168–173.
Appel Hort, M., DalBo, S., Brighente, I.-M.-C., Pizzolatti, M.G., Pedrosa, R.-C., and Ribeiro-do-
Valle, R.-M. 2008. Antioxidant and hepatoprotective effects of Cyathea phalerata Mart.
(Cyatheaceae). Basic & Clinical Pharmacology & Toxicology 103:17–24.
Bagniewska-Zadworna, A., Zenkteler, E., Karolewski, P., and Zadworny, M. 2008. Phenolic com-
pound localisation in Polypodium vulgare L. rhizomes after mannitol-induced dehydration and
controlled desiccation. Plant Cell Reports 27:1251–1259.
Beaujard, P. 1988. Plantes et médecine traditionnelle dans le Sud-Est de Madagascar. Journal of
Ethnopharmacology 23:165–185.
Beltran, R., Mateo, M., and Ascension, P. 1982. Precomunicacion sobre un nuevo tratamiento
efectuado con 48 niños afectados de dermatitis atopica. Actualidad Dermatologica 10:52–55.
Ben Cao, Z.B. 1999. Editorial committee of the administration bureau of traditional Chinese
medicine. pp.122–124. Shangai: Shangai Science & Technology Press.
Benjamin, A. and Manickam, V. S. 2007. Medicinal pteridophytes from the Western Ghats. Indian
Journal of Traditional Knowledge 6:611–618.
Benoit, E., Laurent, D., and Mattei, C. 2000. Reversal of Pacific ciguatoxin-1B effects on myelinated
axons by agents used in ciguatera treatment. Cybium 24:33–40.
Bloomfield, S.F. 2002. Illness and cure in Tonga. Tonga: Vava’u Press.
Bonet, M. A. and Vallès, J. 2007. Ethnobotany of Montseny biosphere reserve (Catalonia, Iberian
Peninsula): plants used in veterinary medicine. Journal of Ethnopharmacology 110:130–147.
Bourdy, G., François, C., Andary, C., and Boucard, M. 1996. Maternity and medicinal plants in
Vanuatu II. Pharmacological screening of five selected species. Journal of Ethnopharmacology
52:139–143.
Bresciani, L.F., Priebe, J.P., Yunes, R.A., Dal Magro, J., Delle Monache, F., de Campos, F., de
Souza, M.M., and Cechinel-Filho, V. 2003. Pharmacological and phytochemical evaluation of
Adiantum ceneatum growing in Brazil. Zeitschrift für Naturforschung [C] 58:191–194.
Bustillos, F., Young, F., and Almanza, G. 2002. Triterpenoids from Polypodium decumanum.
Revista Boliviana de Quimica 19:34–38.
Cambie, R.C. and Ash, J. 1994. Fijian medicinal plants. Melbourne: CSIRO.
Chang, H.-C., Huang, G.-J., Agrawal, D.C., Kuo, C.-L., Wu, C.-R., and Tsay, H.-S. 2007.
Antioxidant activities and polyphenol contents of six folk medicinal ferns used as “Gusuibu.”
Botanical Studies 48:397–406.
Cui, C.B., Tezuka, Y., Kikuchi, T., Nakano, H., Tamaoki, T., and Park, J.H. 1990. Constituents of
fern, Davallia mariesii Moore. I. Isolation and structures of davallialactone and a new flavanone
glucuronide. Chemical & Pharmaceutical Bulletin 38:3218–3225.
Cui, C.B., Tezuka, Y., Kikuchi, T., Nakano, H., Tamaoki, T., and Park, J.H. 1992. Constituents of
a fern, Davallia mariesii Moore II. Identification and 1H and 13C-nuclear magnetic resonance
spectra of procyanidin B-5, epicatechin-(4beta-- > 6)-epicatechin, and epicatechin-
(4beta-- > 6)-epicatechin-(4beta-- > 8) epicatechin-(4beta-- > 6)-epicatechin. Chemical &
Pharmaceutical Bulletin 40:889–898.
Dall’Acqua, S., Tome, F., Vitalini, S., Agradi, E., and Innocenti, G. 2009. In vitro estrogenic activity
of Asplenium trichomanes L. extracts and isolated compounds. Journal of Ethnopharmacology
122:424–429.
Das, K. and Einstein, J.W. 2007. Samambaia – The future focus for Indian researchers in the treat-
ment of psoriasis. Thai Journal of Pharmaceutical Sciences 31:45–51.
De Feo, V. 2003. Ethnomedical field study in northern Peruvian Andes with particular reference
to divination practices. Journal of Ethnopharmacology 85:243–256.
DeFilipps, R.A., Maina, S.L., and Pray, L.A. 1998. The Palauan and Yap medicinal plant studies
of Masayoshi Okabe, pp. 1941–1943. Washington: National Museum of Natural History
Smithsonian Institution.
Dhiman, A.K. 1998. Ethnomedicinal uses of some pteridophytic species in India. Indian Fern
Journal 15:61–64.
Duke, J.A. 2001. Handbook of phytochemical constituents of grass herbs and other economic
plants. London: CRC Press.
23 Ferns: From Traditional Uses to Pharmaceutical Development 343
Garcia, F., Pivel, J.P., Guerrero, A., Brieva, A., Martinez-Alcazar, M.P., and Caamano-Somoza, M.
2006. Phenolic components and antioxidant activity of fernblock, an aqueous extract of the
aerial parts of the fern Polypodium leucotomos. Methods and Findings in Experimental and
Clinical Pharmacology 28:1–4.
Ge, X., Ye, G., Li, P., Tang, W.-J., Gao, J.-L., and Zhao, W.-M. 2008. Cytotoxic diterpenoids and
sesquiterpenoids from Pteris multifida. Journal of Natural Products 71:227–231.
Gombau, L., Garcia, F., Lahoz, A., Fabre, M., Roda-Navarro, P., Majano, P., Alonso-Lebrero,
J. L., Pivel, J.P., Castell, J.V., and Gomez-Lechon, M.J. 2006. Polypodium leucotomos extract:
antioxidant activity and disposition. Toxicology in vitro 20:464–471.
Gonzalez, S. and Pathak, M.A. 1996. Inhibition of ultraviolet-induced formation of reactive oxygen
species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomos.
Photodermatology, Photoimmunology & Photomedecine 12:45–56.
Gonzalez, S., Gilaberte, Y., and Philips, N. 2010. Mechanistic insights in the use of a Polypodium
leucotomos extract as an oral and topical photoprotective agent. Photochemical &
Photobiological Sciences 9:559–563.
Grepin, F. and Grepin, M. 1984. La médicine tahitienne traditionnelle – Raau Tahiti. Polynésie
française: Edition du Pacifique.
Grierson, D.S. and Afolayan, A.J. 1999. Antibacterial activity of some indigenous plants used for
the treatment of wounds in the Eastern Cape, South Africa. Journal of Ethnopharmacology
66:103–106.
Grzybek, J. 1983. Phytochemical and biological investigations on Polypodium vulgare L. Acta
Poloniae Pharmaceutica 2:259–263.
Hammond, G. B., Fernandez, I. D., Villegas, L. F., and Vaisberg, A. J. 1998. A survey of tradi-
tional medicinal plants from the Callejon de Huaylas, Department of Ancash, Perú. Journal of
Ethnopharmacology 61:17–30.
Ho, R., Teai, T., Loquet, D., Bianchini, J.-P., Girault, J.-P., Lafont, R., and Raharivelomanana, P.
2007. Phytoecdysteroids in the genus Microsorum (Polypodiaceae) from French Polynesia.
Natural Product Communications 2:803–806.
Ho, R., Girault, J.-P., Cousteau, P.-Y., Bianchini, J.-P., Raharivelomanana, P., and Lafont, R. 2008.
Isolation of a new class of ecdysteroid conjugates (glucosyl-ferulates) using a combination of
liquid chromatographic methods. Journal of Chromatographic Science 46:102–110.
Hostettmann, K., Borloz, A., Urbain, A., and Marston, A. 2006. Natural product inhibitors of
acetylcholinesterase. Current Organic Chemistry 10:825–847.
House, R.P., Lagos, S., Ochoa, L., Torres, C., Mejia, T., and Rivas, M. 1994. Plantas medicinales
communes de Honduras. Honduras: UNAH-CIMN-HCID/CIIR.GTZ.
Hu, H. and Zheng, X. 2004. Studied on the chemical compositions of Pteris multifida Poir.
Tianran Chanwu Yanjiu Kaifa 16:379–382.
Hu, H. and Zheng, X. 2005. Studied on the chemical compositions from the roots of Pteris multifida
Poir. Tianran Chanwu Yanjiu Kaifa 17:169–171.
Hu, H., Jian, Y., Zheng, X., Liu, J., and Cao, H. 2006. A new sesquiterpene glycoside from the
roots of Pteris multifida Poir. Indian Journal of Chemistry, 45B:1274–1277.
Jimenez, D., Naranjo, R., Doblare, E., Muñoz, C., and Vargas, J.F. 1987. Anapsos an antipsoriasis
drug, in atomic dermatitis. Allergologia et Immunopathologia 15:185–189.
Lafont, R. and Dinan, L. 2003. Practical uses for ecdysteroids in mammals and humans: an update.
Journal of Insect Science 3:7. http://www.insectscience.org/3.7
Lee, S., Xiao, C., and Pei, S. 2008. Ethnobotanical survey of medicinal plants at periodic markets of
Honghe prefecture in Yunnan Province, SW China. Journal of Ethnopharmacology 117:362–377.
Liu, C.-X., Xiao, P.-G., and Song, N.-N. 2009. Traditional Chinese medicines: the challenge of
acceptance by western medicine. In Evaluation of herbal medicinal p;roducts, ed P. Houghton
and P.K. Mukherjee, pp 42–61. London: Pharmaceutical Press.
Liu, J.S., Yu, C.M., Zhou, Y.Z., Han, Y.Y., Wu, F.W., Qi, B.F., and Zhu, Y.L. 1986a. Study on the
chemistry of huperzine-A and huperzine-B. Acta Chimica Sinica 44:1035–1040.
Liu, J.S., Zhu, Y.L., Yu, C.M., Zhou, Y.Z., Han, Y.Y., Wu, F.W., and Qi, B.F. 1986b. The structures
of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity.
Canadian Journal of Chemistry 64:837–839.
344 R. Ho et al.
Lopez, M. and Vargas, J.F. 1988. Anapsos, una nueva orientacion terapeutica en las manifestaciones
digestivas del estado atopico. Acta Pediatrica Espanola 46:556–561.
Lucca, D.M. 1992. Flora medicinal Boliviana : Dicccionario Enciclopedico. Bolivia: Editorial Los
Amigos del Libro.
Ma, X., Tan, C., Zhu, D., Gang, D.R., and Xiao, P. 2007. Huperzine A from Huperzia species – An
ethnopharmacological review. Journal of Ethnopharmacology 113:15–34.
Martin, K.P., Sini, S., Zhang, C.-L., Slater, A., and Madhusoodanan, P.V. 2006. Efficient induction
of apospory and apogamy in vitro in silver fern (Pityrogramma calomelanos L.). Plant Cell
Reports 25:1300–1307.
Meybeck, A., Ho, R., Teai, T., and Raharivelomanana, P. 2010. Use of aqueous or organic or aqueous-
organic extract of “Microsorum.” PCT Int. Appl., CODEN:PIXXD2 WO 2010007247(A2).
Moerman, D.E. 1998. Native American Ethnobotany. Oregon: Timber Press.
Morrison, J., Geraghty, P., and Crowl, L. 1994. Fauna, flora, food and medicine – science of
Pacific Island peoples vol. III. Suva: Institute of Pacific Studies.
Nakane, T., Maeda, Y., Ebihara, H., Arai, Y., Masuda, K., Takano, A., Ageta, H., Shiojima, K.,
Cai, S.Q., and Abdel-Halim, O.B. 2002. Fern constituents: triterpenoids from Adiantum capillus-
veneris. Chemical and Pharmaceutical Bulletin 50:1273–1275.
Nguyen, K.H. 2005. Assessment of anti-diabetic effect of Vietnamese herbal drugs. Endocrine and
Diabetes Unit, Department of Molecular Medicine and Surgery. Sweden: Karolinska
Institute.
Negri, G. 1979. Descrizione e proprieta delle plante medicinali e velenose. In Nuovo erbario figu-
rato, ed. Hoepli, pp. 19–20. Milano: Vitalita.
Nonato, F. R., Barros, T. A. A., Luchesse, A. M., Oliviera, C. E. C., Ribeiro dos Santos, R., Soares,
M. B. P., and Villareal, C. F. 2009. Antiinflammatory and antinociceptive activities of
Blechnum occidentale L. extract. Journal of Ethnopharmacology 125:102–107.
Nooteboom, H.P. 1997. The microsoroid ferns (Polypodiaceae). Blumea 42:261–395.
Oniga, I., Toiu, A., Mogosan, C., and Bodoki, E. 2004. Preliminary investigations of Phyllitis
scolopendria (L.) Newman (Polypodiaceae). Farmacia 52:48–54.
Ouyang, D., Yang, P., and Kong, D. 2008. Chemical constituents from Pteris multifida Poir.
Zhongguo Yiyao Gongye Zazhi 39:898–900.
Ouyang, D., Kong, D., Xu, H., Ni, X., Chen, J., and Yang, P. 2009. Isolation and purification of
apigenin and luteolin from Pteris multifida Poir. by high-speed counter-current chromatography.
Tianran Chanwu Yanjiu Yu Kaifa 21:822–825.
Pareja, B. 1988. Therapeutic properties of Polypodium angustifolium. Boletin de la Sociedad
Quimica del Peru 54:89–95.
Parihar, P., Parihar, L., and Bohra, A. 2010. In vitro antibacterial activity of fronds (leaves) of
some important pteridophytes. Journal of Microbiology and Antimicrobials 2:19–22.
Pétard, P. 1986. Plantes utiles de Polynésie et Raau Tahiti. Polynésie française: Haere po no
Tahiti.
Pomini, L. 1990. Erborista Italiana. Italy: Vitalità.
Ramanitrahasimbola, D., Rakotondramanana, D.A., Rasoanaivo, P., Randriantsoa, A.,
Ratsimamanga, S., Palazzino, G., Galeffi, C., and Nicoletti, M. 2005. Bronchodilator activity
of Phymatodes scolopendria (Burm.) Ching and its bioactive constituent. Journal of
Ethnopharmacology 102:400–407.
Reddy, V.L., Ravikanth, V., Rao, T.P., Diwan, P.V., and Venkateswarlu, Y. 2001. A new triterpe-
noid from the fern Adiantum lunulatum and evaluation of antibacterial activity. Phytochemistry
56:173–175.
Reixach, N., Irurre-Santilari, J., Camps, F., Mele, E., Messeguer, J., and Casas, J. 1997. Phytoecdysteroid
overproduction in Polypodium vulgare prothalli. Phytochemistry 46:1183–1187.
Rout, S. D., Panda, T., and Mishra, N. 2009. Ethnomedicinal studies on some pteridophytes of
Similipal Biosphere Reserve, Orissa, India. International Journal of Medicine and Medical
Sciences 1:192–197.
Santos, R.C., Brasileiro Filho, G., and Hojo, E.S. 1987. Induction of tumors in rats by bracken
fern (Pteridium aquilinum) from Ouro Preto (Minas Gerais, Brazil). Brazilian Journal of
Medical and Biological Research 20:73–77.
23 Ferns: From Traditional Uses to Pharmaceutical Development 345
Sempere-Ortells, J.M., Campos, A., Velasco, I., Marco, F., Ramirez-Bosca, A., Diaz, J., and
Pardo, J. 2002. Anapsos (Polypodium leucotomos) modulates lymphoid cells and the expres-
sion of adhesion molecules. Pharmacological Research 46:185–190.
Singh, M., Singh, N., Khare, P.B., and Rawata, K.S. 2008. Antimicrobial activity of some important
Adiantum species used traditionally in indigenous systems of medicine. Journal of Ethnopharmacology
115:327–329.
Snogan, E., Vahirua-Lechat, I., Ho, R., Bertho, G., Girault, J.-P., Ortiga, S., Maria, A., and Lafont,
R. 2007. Ecdysteroids from the medicinal fern Microsorum scolopendria (Burm. f.).
Phytochemical Analysis 18:441–450.
Suffredini, I. B., Bacchi, E. M., and Sertié, J. A. A. A. 1999. Antiulcer action of Microgramma
squamulosa (Kaulf.) Sota. Journal of Ethnopharmacology 65:217–223.
Tang, X.C. 1996. Huperzine A shuangyiping: a promising drug for Alzheimer’s disease. Zhongguo
Yao Li Xue Bao 17:481–484.
Upreti, K., Jalal, J.S., Tewari, L.M., Joshi, G.C., Pangtey, Y.P.S., and Tewari, G. 2009.
Ethnomedicinal uses of Pteridophytes of Kumaun Himalaya, Uttarakhand, India. Journal of
American Science 5:167–170.
Vasange-Tuominen, M., Perera-Ivarsson, P., Shen, J., Bohlin, L., and Rolfsen, W. 1994. The fern
Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as
inhibitors of leukotriene B4 formation. Prostaglandins, Leukotrienes and Essential Fatty Acids
50:279–284.
Vasudeva, S.M. 1999. Economic importance of pteridophytes. Indian Fern Journal 16:130–152.
Wang, G. and Zhang, L.-M. 2008. Study of the extract from Pteris multifida Poir. on antitumor
activity. Hebeisheng Kexueyuan Xuebao 25:52–54.
Wei, G.L., Xiao, S.H., Lu, R., and Liu, C.X. 2006. Simultaneous determination of ZT-1 and its
metabolite huperzine A in plasma by high-performance liquid chromatography with ultraviolet
detection. Journal of Chromatography B 830:120–125.
Wei, H.-A., Lian, T.-W., Tu, Y.-C., Hong, J.-T., Kou, M.-C., and Wu, M.-J. 2007. Inhibition of
low-density lipoprotein oxidation and oxidative burst in polymorphonuclear neutrophils by
caffeic acid and hispidin derivates isolated from sword brake ferns (Pteris ensiformis Burm.).
Journal of Agricultural and Food Chemistry 55:10579–10584.
Whistler, W.A. 1992a. Polynesian Herbal Medecine. Hawaii: National Tropical Botanical
Garden.
Whistler, W.A. 1992b. Tongan Herbal Medicine. Hawaii: National Tropical Botanical Garden.
Whistler, W.A. 1996. Samoan herbal medicine. Hawaii: Isle Botanica.
WHO: World Health Organization. 1998. Medicinal plants in the South Pacific. Manila: WHO
regional publications.
Woerdenbag, H.J., Lutke, L.R., Bos, R., Stevens, J.F., Hulst, R., Kruizinga, W.H., Zhu, Y.P.,
Elema, E.T., Hendriks, H., and van Uden, W. 1996. Isolation of two cytotoxic diterpenes from
the fern Pteris multifida. Journal of Biosciences 51:653–638.
Xu, R.S. and Zhao, W.M. 2005. New drugs research on basis of active compounds in traditional
Chinese medicines. The Chinese Journal of Natural Medecine 3:322–327.
Yamada, K., Ojika, M., and Kigoshi, H. 2007. Ptaquiloside, the major toxin of bracken, and
related terpene glycosides: chemistry, biology and ecology. Natural Product Reports
24:798–813.
Yonathan, M., Asres, K., Assefa, A., and Bucar F. 2006. In vivo anti-inflammatory and anti-nociceptive
activities of Cheilanthes farinosa. Journal of Ethnopharmacology 108:462–470.
Zangara, A. 2003. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing
and neuroprotective properties of interest in the treatment of Alzheimer’s disease. Pharmacology,
Biochemistry and Behavior 75:675–686.
Zhang, H.Y., Zheng, C.Y., Yan, H., Wang, Z.F., Tang, L.L., Gao, X., and Tang, X.C. 2008.
Potential therapeutic targets of huperzine A for Alzheimer’s disease and vascular dementia.
Chemico-Biological Interactions 175:396–402.
Zhang, Z., ElSohly, H.N., Jacob, M.R., Pasco, D.S., Walker, L.A., and Clark, A.M. 2002. Natural
products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cernum.
Journal of Natural Products 65:979–985.
346 R. Ho et al.
Zheng, X.-D., Hu, H.-B., and Hu, H.-S. 2008a. A new neolignan glycoside from Pteris multifida
Poir. Bulletin of the Korean Chemical Society 29:1250–1252.
Zheng, X.-D., Hu, H.-B., and Hu, H.-S. 2008b. Two new neolignan glycosides from Pteris multifida
Poir. Indian Journal of Chemistry 47B:773–777.
Zheng, X.-L. and Xing, F.-W. 2009. Ethnobotanical study on medicinal plants around Mt.
Yinggeling, Hainan Island, China. Journal of Ethnopharmacology 124:197–210.
Zhu, D.Y., Tang, X.C., and Lin, C. 1999. Huperzine, a derivate, their preparation and their use. US
Patent 5929084 07/27/1999.
Zhu, D.Y., Tang, X.C., and Lin, C. 2000. Huperzine, a derivate, their preparation and their use.
Chinese Patent 59196884X, 05/10/2000.